US3620947A - Electrophoretic system - Google Patents

Electrophoretic system Download PDF

Info

Publication number
US3620947A
US3620947A US815145A US3620947DA US3620947A US 3620947 A US3620947 A US 3620947A US 815145 A US815145 A US 815145A US 3620947D A US3620947D A US 3620947DA US 3620947 A US3620947 A US 3620947A
Authority
US
United States
Prior art keywords
gel
ion
buffer
borate
resolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US815145A
Inventor
Robert Carter Allen
Dorothy J Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EG&G Instruments Inc
Original Assignee
Ortec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortec Inc filed Critical Ortec Inc
Application granted granted Critical
Publication of US3620947A publication Critical patent/US3620947A/en
Anticipated expiration legal-status Critical
Assigned to EG&G INSTRUMENTS, INC. reassignment EG&G INSTRUMENTS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). DECEMBER 28, 1988 - DE Assignors: PRINCETON APPLIED RESEARCH CORPORATION, ORTEC INCORPORATED INTO
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor

Definitions

  • ABSTRACT An electrophoretic system for concentrating [56] References cued and separating charged particles and for improving the resolu UNITED STATES PATENTS tion of the separated particle laminae that utilizes a buffer 3,539,494 1 H1970 Pretorius et al 204/299 composition which will provide a ratio of leading-trailing ion 3,384,564 5/1968 Omstein et al o o 204/180 boundary to the fastest particle mobility that approaches um- 3,470,080 9/1969 Raymond et al. 204/] 80 ty, during the period offree electrophoresis.
  • Electrophoresis particularly that carried out in a molecularly sieving medium such as starch gel and more importantly in acrylamide gel, represents one of the most effective procedures for the separation of charged particles.
  • a major problem in such gel electrophoresis whether carried out with either single ion buffer systems or discontinuous buffer ion systems or in discontinuous pH and buffer ion combination systems, has been in the separation and consequent quantification of isoenzymes, i.e., multiple molecular forms of the same enzyme.
  • isoenzymes i.e., multiple molecular forms of the same enzyme.
  • a thin gel slab is desirable also for the following additional reasons: (1) temperature and voltage are identical across the entire slab, and (2) slabs due to their flat surfaces, are considerably more suitable for densitometric analysis due to the absence of combinations of vertical alignment usually encountered with cylindrical shapes.
  • the present invention provides an electrophoretic system for concentrating and separating charged particles resulting in an improved resolution of the separated particle laminae by utilizing a buffer combination which provides a ratio of leading-trailing ion boundaries to fastest particle mobility that approaches unity, during the period of free electrophoresis.
  • the buffer combination and pH range, together with the gel buffering concentration is carefully chosen so that a discontinuous buffer ion and continuous gel pH system is provided to produce the enhanced resolution of separated particle laminae.
  • Another object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system wherein two sequential, rapidly moving ionic boundaries pass through the components that had been previously separated, resulting in a sharpened zone as the boundaries formed at the leading and trailing ions pass through each zone.
  • Another object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system wherein an enhanced resolution of various, similar size particles, in a mixture of many sizes of particles is achieved by providing gradient pore size gels so that particles differing only slightly in size with similar charges, may be maximally resolved.
  • Still another object of the present invention is to provide a two-step, continuous pH, discontinuous buffer ion electrophoresis system utilizing a continuous pH gel and a discontinuous buffer ion solution to enhance the resolution of the separated particle laminae.
  • Yet another object of the present invention is to provide a two-step, continuous pH, discontinuous buffer ion electrophoresis system capable of producing increased resolution by selection of leading-trailing buffer ion and gel combinations such that conductivity differences may be used to effect changes in separation time and resolution in various areas, as may be desired by the operator.
  • a further object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system which allows simultaneous separation of various types of particles on the same gel slab under a set of conditions for maximal resolution for each sample, to allow for the simultaneous analysis of proteins and enzymes from plasma together with tissue extracts from various species.
  • FIG. 1a is an exploded view of the buffer tanks and electrodes for our flatbed, vertical, continuous pH, discontinuous buffer ion electrophoresis system
  • FIG. lb is the typical cell configuration of FIG. la;
  • FIG. 2 is an isometric representation of the gel portion of our electrophoretic system after insertion of a sample but before application of the appropriate electrical potential;
  • FIG. 3 is an isometric representation of the gel portion of the same system after power has been applied for a given duration and shall hereinafter be referred to as phase I
  • FIG. 4 is an isometric representation of the system of FIG. 3 after electrical power has been applied for a longer given period than in FIG. 3 and is hereinafter referred to as phase 2";
  • FIG. 5 is an isometric representation of the system of FIG. 3 and 4 after the separation process has been completed.
  • FIGS. 1a and 1b there is shown the tank system for performing our novel electrophoresis process.
  • Lower tank 12 is provided with sidepieces 12.5, end walls 12.3 and an electrode 12.2. End walls 12.3 are further provided with shoulders 12.4 so that when the lower tank 12 is filled with an appropriate buffer solution, (not shown) upper tank 14 will be properly positioned therein.
  • Electrode 12.2 is preferably made of platinum or some other inert material that is not affected by either the buffer solution nor the passage of current therethrough and terminates in and is connected to a jack 12.1 which passes through one wall 12.3 so that an appropriate source of power may be applied thereto.
  • Upper tank 14 is also provided with sidewalls 14.6 as well as end walls 14.2 which end walls are also provided with appropriate slotted portions 14.3 for accepting and holding the upper electrode or cathode wire 16.2.
  • the bottom or floor member 14.4 is provided with plurality of apertures 14.5 so that cell members 14.51 may be placed therein.
  • upper electrode 16 is provided and consists of a platinum wire 16.2 supported by dielectric member 16.1.
  • the upper electrode or cathode wire 16.2 is provided with a loop or some other appropriate means for connection to jack 14.1 so that power may be applied thereto by any of the many well known conventional methods.
  • One example of such source of power is disclosed in the copending US. Pat. Application Ser. No. 736,642 of Robert H. Dilworth, III, entitled Process and Apparatus for Particle Separation, on June 13, i968 and assigned to the assignee of the subject application.
  • cell 14.51 is provided with an upper flange portion 14.52 and a body portion 14.53 having a slotted tapered portion 14.54 extending the length thereof.
  • a sample as will hereinafter be described with regard to Figs. 2-5 is prepared and placed in the slotted portion 14.54 of cell 14.51. Thereafter, the underside of flange portion 14.52 is provided with a nonconductive fluid seal and cell 14.51 is inserted into aperture 14.5 of upper tank 14. It should be apparent, to those skilled in the art, that the unused sample cell apertures in the bottom wall 14.4 of tank 14 are blocked or otherwise covered if not in use.
  • lower tank 12 is filled with the selected buffer solution, to the desired level, and upper tank 14, with the inserted cells 14.51, is placed into tank 12 to rest on shoulders 12.4.
  • Upper tank 14 is then provided with a sufficient amount of buffer solution, electrode support 16 is placed in notches 14.3 and the looped portion of cathode 16.2 is connected to jack 14.1.
  • the system is now ready for operation upon the application of a suitable potential across jacks 12.1 and 14.1.
  • FIGS. 25 there is shown an isometric representation of a rectangular cell as it would be when completely immersed in cold buffer in the lower tank 12 (FIG. 1) and containing a typical vertical gel slab 18 capable of separating from one to twelve samples
  • FIG. 2 denotes the typical electrochemical setup of the system after appropriate amounts of the sample 20 have been placed in well portion 22 and prior to the application of electrical energy.
  • FIG. 3 illustrates the initial separation and concentration, beginning with the application of power and due to the conductivity shift phase of the separation. The particles have all been initially partially concentrated and separated prior to the trailing ion boundary 24 and leading ion boundary 26 overtaking the particles 28, even though the ionic boundaries are moving (during the conductivity shift phase) at five to 10 times the velocity of the particles to be separated. At this point, the power is gradually increased by increasing the pulse rate at which the power is applied.
  • the moving boundary formed by the trailing and leading anion layers 24 and 26 passes sequentially through each lamina of protein or particles 28 separated and molecularly sieved in phase I of our procedure.
  • Each lamina 28 is sequentially caught in a zone 32, 34 or 36 that has been depleted of trailing and leading ions and thus having high-voltage gradient.
  • This high-voltage gradient region moves through the lamina, the rear portion of the lamina, which the high-voltage gradient region encounters first, is speeded up and moves faster than the front portion of the lamina which has not yet been reached by the high-voltage gradient region. This process effectively compresses each successive lamina into an ultrathin layer as the high-voltage gradient region of the moving boundary passes through.
  • the ultrathin protein laminae 28 travel at their own mobilities as in conventional acrylamide electrophoresis.
  • FIGS. 4 and 5 show the leading 26 and trailing 24 ion boundaries after passing sequentially through a portion of the laminae initially separated in FIG. 3, where a resharpening of laminae has taken place along with a greatly increased lamina mobility. At this time a maximum pulse rate of constant power consistent with maximal resolution is employed and FIG. 5 illustrates a completed plasma protein separation.
  • the system illustrated takes particular advantage of both the conductivity shift procedure and the moving ion boundary, along with the molecular sieving effects of the gradient gel, as shown in this illustration, for maximum resolution in regions of both high and low molecular size particles.
  • band widths as small as 25 to 50 microns by actual measurement are found to be present .following separation.
  • 25 or more protein bands can be resolved from human plasma over a distance of 3.5 to 4 centimeters in 40 to 60 minutes under conditions sufficiently mild so that easily inactivated substances such as mouse plasma esterases and tissue extract isoenzymes suitable for quantitative studies can be separated simultaneously on the same gel.
  • FIGS. 1, 2, and 3 and our FIGS. 2-5 In comparing the electrochemistry of this disclosure with the method described by Ornstein and Davis in US. Pat. No. 3,384,564, particular attention must be paid to their FIGS. 1, 2, and 3 and our FIGS. 2-5. It is evident that, at all times, as shown in their FIGS. 1 and 2 that the totality of the protein sample or particles to be separated, is located or sandwiched between the trailing glycine ion and the leading chloride ion, in a zone relatively depleted of leading and trailing ions; thus all particles or proteins are in a region of high-voltage gradient.
  • the choice of the best leading and trailing ions for maximal resolution in our system can be determined to be related to the ratio of the mobility of the ion boundary to that of the fastest particle to be separated after such particle has migrated a unit distance. Thus the lowest ratio tends to produce the best resolution.
  • the polyacrylamide slab (FIGS: 2-5) in cell 14.51 (FIG. 1a) is prepared in two or more layers of recrystallized acrylamide at the desired gel concentration and at the same pH, with five layers typically being used in plasma protein and isoenzyme separations. As shown in FIGS. 2-5, for plasma separations a lower separating layer 36 of between 8 8 Sipercent gel is followed by a layer 34 of between 6 6 1% percent gel which is overlayered directly on layer 36. Layer 34 is then waterlayered to produce an optically flat surface and a 4 A percent gel layer 32 is cast on top, waterlayered and allowed to polymerize.
  • Wells 22 are then cast on top of this layer, with the aid of a well former (not shown), of between 8 8 1% percent gel, at an ionic strength 1/5 to l/lO of the previously casts gels.
  • Samples 20 in 50 percent sucrose buffered to the same pH and ionic strength as the gel columns separating each well are then placed in the wells.
  • each well is then filled to the top level of the cell with between 8 8 as percent acrylamide gel, at the lower ionic strength and consists of the gel cap 30.
  • the interface between the 4 '25 percent gel and the 6 6 A percent gel should be an Boundary and plasma albumin from mobility at 75 me. constant current, pH 9.35, and
  • borate, sulfate and citrate ions do not produce an initial pink background in the gel following reactions for esterase isoenzymes as does glycine.
  • borate-sulfate or borate-citrate are also preferable not only in 551E666 bu t beea use they produce less background for subsequent densitometric studies.
  • citrate like Tris, has
  • RECRYSTALLlZATlON PROCEDURE Dissolve grams of acrylamide monomer in a mixture of 300 ml. ethyl acetate and 300 ml. of benzene and bring to 70 C. in a water bath.
  • the monomer should be recrystallized in an ice water bath.
  • the temperature of solution in the flask should not be allowed to drop below 20 C.
  • the crystals are then removed by vacuum filtration in a Buchner funnel with No. l Whatman paper.
  • the crystals are dried until there is no further odor of benzene. They are then redissolved in 540 ml. of chloroform and heated to 60 C. in a water bath. The solution is again filtered hot and then cooled to no lower than 22 C. and the crystals removed again by vacuum filtration.
  • Crystals may be stored in the cold by placing them in a dark bottle and adding just enough chloroform to cover the crystals. Monomer stored using this procedure has been found to produce suitable isoenzyme separations after 5 months storage at 8 C. Since acrylamide is very reactive monomer, several useful hints and observations may be used to indicate the shelf life of each recrystallized batch.
  • a pH change of0.4 units from the 4.9-5.2 pH of the freshly recrystallized monomer and problems of removal of gel from the cells are both early signs which indicate that the monomer is deteriorating and which can be determined before changes in isoenzyme resolution become apparent.
  • Tris sulfate pH 9.0 0.30M Tris sulfate pH 9.0 0.30M:
  • sucrose trls sulfate pH 9.0 0.075M buffered 6.25 ml. trls sulfate pH 9,0 0.30M from above 12.5 gm. sucrose 0.1 ml. 0.1% aqueous bromphenol blue 11.0 ml. H2O
  • All molarities refer to molarity of tris. All pH refer to pH at 25C.
  • Stock solution 60 is a stock persulfate catalyst solution prepared fresh daily and consists of 0.105 g. ammonium persulfate diluted to 100 m1.
  • Stock 6b is a similar stock persulfate catalyst at double the concentration of 6a, i.e., 0.21 g./ 100 ml.
  • This stock solution is prepared fresh daily.
  • the cell is clamped in an appropriate gelling stand and the stand leveled.
  • a gasket is usually provided at the base of the cell to prevent leakage during additionof reagents.
  • milliliters of a 4 A percent gel consisting of 0.80 ml. of stock solution la, 2a or 3a, 0.45 ml. of stock solution 7, 0.35 ml. of H 0 and 1.6 ml. of stock solution 6b is added and waterlayered.
  • 3.6 ml. of 0.075 molar 8 percent gel consisting of 0.90 ml. of stock solution 7, 0.90 ml. of stock solution lb, 2b or 3b and 1.8 ml. of stock solution 6b, is added, a well former inserted with the bottom edges of the well former resting on top of the 4 1% percent layer, and the gel allowed to polymerize for at least 20 minutes.
  • the well former is then removed and the wells rinsed with distilled H 0 and then drained carefully by inverting the cell.
  • the cell is then placed in the upright position and the sample (200 to 1,000 ug. of protein per wall depending on the test) in 20 pl. of 0.075 molar 50 percent sucrose from stock solution it", 2c or 30 is placed in the well.
  • This sealing gel consists of 1.0 ml. of stock solution 7, 1.0 ml. of stock solution lb, 2b or 3b, and 2.0 ml. of stock solution 6a. This is allowed to gel and the cell is then ready for electrophoretic separation.
  • Solutions 1, 2 or 3 must not be intermixed in the same gel, as each gel slab contains either all Tris citrate (solutions la, lb and 1c) or all Tris sulfate (solutions 2a, 2b and 2c) or all Tris chloride (solutions 3a, 3b and 3c).
  • the cell is cast in the inverted position and the polarities at jacks 12.1, 14.1 (FIG. la) reversed.
  • Electrophoresis is usually performed in the vertical position, preferably with the negatively charged electrode 16.2 (FIG. 1) in the upper tank 14 and the positively charged electrode 12.2 the the lower tank 12.
  • the lower tank is filled with Tris-borate buffer at 40 C., giving a pH of 9.35 to 9.40, to a level even with the bottom of the upper buffer tank 14.
  • the cell or cells 14.51 containing the gel slab l8 and sample 20 are inserted through slots 14.5 in the upper tank 14.
  • the cell end plates are sealed to the floor of the upper tank by pressing the cell and plate into a head of silicone grease or a special sealing gasket (not shown). Then sufficient Tris-borate is poured into the upper tank to cover the platinum electrode wire 16.2.
  • the gel serves as a bridge between the two electrodes and the cell is completely immersed in a large volume of cold buffer for additional cooling during electrophoresis.
  • An electromotive force is then applied across the cell, preferably in the form of constant power pulses, such as described in the aforementioned copending patent application of Robert Dillwoth, 111.
  • the pulse rate is initially set at a level so that a power level at about 45 milliwatts per mm. gel surface is achieved, c.g., for a standard cell, 3.5 mm. width, 100 mm. length and 90 mm. depth, a peak voltage of about 700 v. is discharged through a 1.0 microfarad capacitor at a rate of about 45pulses per second.
  • the power level is then raised to milliwatts/mm. (125 p.p.s.) after 5 minutes.
  • the power is raised in two steps to and .milliwatts/mm. at 15 and 20 minutes, respectively (200 and carried out for both protein and isoenzyme separations typically at power levels of 100 milliwatts/mm. gel surface, although higher power levels with shorter run times may be used. Voltage level is kept constant throughout a given run.
  • Pulsed power electrophoresis is carried on until the albumin front migrates a distance of 3.5 to 4.0 cm.,'a matter of 40 to 60 minutes depending on whether the divalent sulfate or trivalent citrate ions are used as the leading ion.
  • the gel may be stained in a common protein dye (such as Amido Black) in 10 percent acetic acid overnight or for 2 hours at 65 C. and then destained by electrophoresis or repeated washing in 10 percent acetic acid with about five acid changes in two days.
  • a common protein dye such as Amido Black
  • the gels may be placed in a pH 6.6, 0.04 M Tris-chloride buffer at 37 C. for 5 minutes and then into a dye substrate system of fast blue RRa-napthyl butyrate at pH 6.6 for minutes for the quantitative development of nonspecific esterase isoenzymes.
  • Some fifty other isoenzyme staining procedures previously described are amenable to these techniques of separation.
  • the buffer solution is a member of the group consisting of citrate-borate, sulfateborate and chloride-borate.

Abstract

An electrophoretic system for concentrating and separating charged particles and for improving the resolution of the separated particle laminae that utilizes a buffer composition which will provide a ratio of leading-trailing ion boundary to the fastest particle mobility that approaches unity, during the period of free electrophoresis.

Description

O Umted States Patent n11 3,620,947
[72] Invento s Ro r Carter Allen; 3,506 554 4/1970 Broome .v 204': so
Dorothy J. Moore, both of Oak Ridge, FOREIGN PATENTS Tenn. pp No. 815.145 833.364 2/l969 ltaly 204480 [22] Filed Apr. 10. 1969 OTHER REFERENCES {45] P n e N "M1971 Schwalbe, Pulsed Field Electrophoresis," Medical Elec [73] Assignee Ortec Incorporated tronics, Internat. Conf. on Med. Electronics, Paris. I959.
Oak Ridge, Tenn. QT34 [64m (1959) Davis, Method and Appt. to Human Serum Proteins" Annalsofth N.Y A'd fS' ,V l.l21,At'l 2. 541 ELECTROPHORETIC SYSTEM Page 424 28 my c'ences e 6Claims,6Drawing Figs. P E J h H M k rtmary xammer- O n ac [52] :LS. Cl. fist/i200? Assistant Examiner A C Prescott E25} F';Zi.f.',;'s';;;;i;1:;1:::;::1:::;;:;....;1:;..1..,;;.i:1...1 204,180R. Mme-MPWadwahdmdP-Wm" 180 G 299 ABSTRACT: An electrophoretic system for concentrating [56] References cued and separating charged particles and for improving the resolu UNITED STATES PATENTS tion of the separated particle laminae that utilizes a buffer 3,539,494 1 H1970 Pretorius et al 204/299 composition which will provide a ratio of leading-trailing ion 3,384,564 5/1968 Omstein et al o o 204/180 boundary to the fastest particle mobility that approaches um- 3,470,080 9/1969 Raymond et al. 204/] 80 ty, during the period offree electrophoresis.
PAIENTEBNUV 16 I97} 3 20 947 SHEET 1 UF 2 ROBERT CARTER ALLEN PAIENTEnuuv 16 I9?! SHEET 2 OF 2 L Qm IQ ROBERT CARTER ALLEN DOROTHY J. MOORE lxvr-ixmRs ELECTROPIIORETIC SYSTEM BACKGROUND OF THE INVENTION This invention relates to an electrophoretic system and more particularly to an improved electrophoretic system for producing greater resolution of the separated particle laminae.
Electrophoresis, particularly that carried out in a molecularly sieving medium such as starch gel and more importantly in acrylamide gel, represents one of the most effective procedures for the separation of charged particles. However, a major problem in such gel electrophoresis, whether carried out with either single ion buffer systems or discontinuous buffer ion systems or in discontinuous pH and buffer ion combination systems, has been in the separation and consequent quantification of isoenzymes, i.e., multiple molecular forms of the same enzyme. (Early qualitative or quantitative changes in a particular isoenzyme profile of an individual may have great significance in the early detection of physiological changes associated with a disease such as cancer, etc., prior to the onset of the present commonly recognized clinical signs.)
The drawback of a continuous buffer system resides in the fact that one must use low current densities and voltage gradients to limit joule heating to levels below that which may destroy enzyme activity. This serves to lengthen separation time with a resultant loss in zone resolution. In addition, excessively long cm.) separations must be performed to obtain adequate resolution.
The use of a discontinuous pH and buffer ion systems, wherein samples to be separated are first polymerized in an anticonvection large pore gel medium, may lead to enzyme inactivation due to free radical formation in the polymerization procedure. In this situation, up to 65 percent of some types of enzyme activity may be lost in such a procedure. While current densities utilized in protein separations with this technique may be employed at levels sufficient to perform separations up to 252 cm. in length in 30 to 40 minutes, current and voltage must, nevertheless be markedly reduced for enzyme separations of even the more heat stable isoenzymes such as esterases. Thus, separations of 75 to 90 minutes are required for acceptable resolution.
With discontinuous ion and pH systems, which require trailing ion migration to be programmed by means of pH differences, and where the counter ion is Tris (hydroxy methyl amino methane), lowering the temperature of the system to separate heat labile enzymes increases the pH of the system approximately 0.03 pH units per degree Centigrade of temperature decrease. Thus, a buffer made up at the proper pH at room temperature will be about 0.7 pH unit higher at 1 C. Since the resolution in the discontinuous pH and ion system depends in major part on the trailing ion mobility being programmed by appropriate pH to be less than that of the slowest particle to be separated during the stacking phase, lowering the temperature sufficiently to protect many enzymes will raise the pH and thus cause the trailing ion to migrate faster than the slower particles, thereby degrading separation quality. The necessity to carefully adjust buffer ion concentrations for the different temperature conditions utilized with this technique for protein and isoenzyme separations severely limits the versatility of this systems.
When it is necessary to separate isoenzymes and proteins of both plasma and tissues, under identical conditions for accurate qualitative and quantitative comparison, a multiple sample gel slab rather than individual separations is most desirable and may, in certain instances, be required.
A thin gel slab is desirable also for the following additional reasons: (1) temperature and voltage are identical across the entire slab, and (2) slabs due to their flat surfaces, are considerably more suitable for densitometric analysis due to the absence of combinations of vertical alignment usually encountered with cylindrical shapes.
SUMMARY OF THE INVENTION The present invention provides an electrophoretic system for concentrating and separating charged particles resulting in an improved resolution of the separated particle laminae by utilizing a buffer combination which provides a ratio of leading-trailing ion boundaries to fastest particle mobility that approaches unity, during the period of free electrophoresis. In our system, the buffer combination and pH range, together with the gel buffering concentration is carefully chosen so that a discontinuous buffer ion and continuous gel pH system is provided to produce the enhanced resolution of separated particle laminae.
It is, therefore, one object of the present invention to provide a two-step, continuous pH, discontinuous buffer ion electrophoresis system, wherein charged components are separated from a starting medium to produce thin laminae in a similar pore separating gel by utilizing a conductivity shift.
Another object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system wherein two sequential, rapidly moving ionic boundaries pass through the components that had been previously separated, resulting in a sharpened zone as the boundaries formed at the leading and trailing ions pass through each zone.
Another object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system wherein an enhanced resolution of various, similar size particles, in a mixture of many sizes of particles is achieved by providing gradient pore size gels so that particles differing only slightly in size with similar charges, may be maximally resolved.
Still another object of the present invention is to provide a two-step, continuous pH, discontinuous buffer ion electrophoresis system utilizing a continuous pH gel and a discontinuous buffer ion solution to enhance the resolution of the separated particle laminae.
Yet another object of the present invention is to provide a two-step, continuous pH, discontinuous buffer ion electrophoresis system capable of producing increased resolution by selection of leading-trailing buffer ion and gel combinations such that conductivity differences may be used to effect changes in separation time and resolution in various areas, as may be desired by the operator.
A further object of the present invention is to provide a twostep, continuous pH, discontinuous buffer ion electrophoresis system which allows simultaneous separation of various types of particles on the same gel slab under a set of conditions for maximal resolution for each sample, to allow for the simultaneous analysis of proteins and enzymes from plasma together with tissue extracts from various species.
The features of our invention which we believe to be novel are set forth with particularity in the appended claims. The invention itself, however, both as to its organization and method of operation, together with further objects and advantages thereof, may best be understood by reference to the following description taken in combination with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1a is an exploded view of the buffer tanks and electrodes for our flatbed, vertical, continuous pH, discontinuous buffer ion electrophoresis system;
FIG. lb is the typical cell configuration of FIG. la;
FIG. 2 is an isometric representation of the gel portion of our electrophoretic system after insertion of a sample but before application of the appropriate electrical potential;
FIG. 3 is an isometric representation of the gel portion of the same system after power has been applied for a given duration and shall hereinafter be referred to as phase I FIG. 4 is an isometric representation of the system of FIG. 3 after electrical power has been applied for a longer given period than in FIG. 3 and is hereinafter referred to as phase 2"; and
for use with the tank FIG. 5 is an isometric representation of the system of FIG. 3 and 4 after the separation process has been completed.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Referring now to FIGS. 1a and 1b, there is shown the tank system for performing our novel electrophoresis process. Lower tank 12 is provided with sidepieces 12.5, end walls 12.3 and an electrode 12.2. End walls 12.3 are further provided with shoulders 12.4 so that when the lower tank 12 is filled with an appropriate buffer solution, (not shown) upper tank 14 will be properly positioned therein. Electrode 12.2 is preferably made of platinum or some other inert material that is not affected by either the buffer solution nor the passage of current therethrough and terminates in and is connected to a jack 12.1 which passes through one wall 12.3 so that an appropriate source of power may be applied thereto.
Upper tank 14 is also provided with sidewalls 14.6 as well as end walls 14.2 which end walls are also provided with appropriate slotted portions 14.3 for accepting and holding the upper electrode or cathode wire 16.2. The bottom or floor member 14.4 is provided with plurality of apertures 14.5 so that cell members 14.51 may be placed therein. To complete the device, upper electrode 16 is provided and consists of a platinum wire 16.2 supported by dielectric member 16.1. The upper electrode or cathode wire 16.2 is provided with a loop or some other appropriate means for connection to jack 14.1 so that power may be applied thereto by any of the many well known conventional methods. One example of such source of power is disclosed in the copending US. Pat. Application Ser. No. 736,642 of Robert H. Dilworth, III, entitled Process and Apparatus for Particle Separation, on June 13, i968 and assigned to the assignee of the subject application.
To operate our device, cell 14.51 is provided with an upper flange portion 14.52 and a body portion 14.53 having a slotted tapered portion 14.54 extending the length thereof.
A sample, as will hereinafter be described with regard to Figs. 2-5 is prepared and placed in the slotted portion 14.54 of cell 14.51. Thereafter, the underside of flange portion 14.52 is provided with a nonconductive fluid seal and cell 14.51 is inserted into aperture 14.5 of upper tank 14. It should be apparent, to those skilled in the art, that the unused sample cell apertures in the bottom wall 14.4 of tank 14 are blocked or otherwise covered if not in use.
Thereafter, lower tank 12 is filled with the selected buffer solution, to the desired level, and upper tank 14, with the inserted cells 14.51, is placed into tank 12 to rest on shoulders 12.4. Upper tank 14 is then provided with a sufficient amount of buffer solution, electrode support 16 is placed in notches 14.3 and the looped portion of cathode 16.2 is connected to jack 14.1. The system is now ready for operation upon the application of a suitable potential across jacks 12.1 and 14.1.
Referring now to FIGS. 25, there is shown an isometric representation of a rectangular cell as it would be when completely immersed in cold buffer in the lower tank 12 (FIG. 1) and containing a typical vertical gel slab 18 capable of separating from one to twelve samples FIG. 2 denotes the typical electrochemical setup of the system after appropriate amounts of the sample 20 have been placed in well portion 22 and prior to the application of electrical energy. FIG. 3 illustrates the initial separation and concentration, beginning with the application of power and due to the conductivity shift phase of the separation. The particles have all been initially partially concentrated and separated prior to the trailing ion boundary 24 and leading ion boundary 26 overtaking the particles 28, even though the ionic boundaries are moving (during the conductivity shift phase) at five to 10 times the velocity of the particles to be separated. At this point, the power is gradually increased by increasing the pulse rate at which the power is applied.
Following this step in our procedure the moving boundary formed by the trailing and leading anion layers 24 and 26 passes sequentially through each lamina of protein or particles 28 separated and molecularly sieved in phase I of our procedure.
Each lamina 28 is sequentially caught in a zone 32, 34 or 36 that has been depleted of trailing and leading ions and thus having high-voltage gradient. As this high-voltage gradient region moves through the lamina, the rear portion of the lamina, which the high-voltage gradient region encounters first, is speeded up and moves faster than the front portion of the lamina which has not yet been reached by the high-voltage gradient region. This process effectively compresses each successive lamina into an ultrathin layer as the high-voltage gradient region of the moving boundary passes through.
After the boundary produced by the trailing and leading ion 24 and 26 has passed through all the protein zones 30, 32, 34 and 36, the ultrathin protein laminae 28 travel at their own mobilities as in conventional acrylamide electrophoresis.
FIGS. 4 and 5 show the leading 26 and trailing 24 ion boundaries after passing sequentially through a portion of the laminae initially separated in FIG. 3, where a resharpening of laminae has taken place along with a greatly increased lamina mobility. At this time a maximum pulse rate of constant power consistent with maximal resolution is employed and FIG. 5 illustrates a completed plasma protein separation.
The system illustrated takes particular advantage of both the conductivity shift procedure and the moving ion boundary, along with the molecular sieving effects of the gradient gel, as shown in this illustration, for maximum resolution in regions of both high and low molecular size particles. Thus, band widths as small as 25 to 50 microns by actual measurement are found to be present .following separation. With the technique, 25 or more protein bands can be resolved from human plasma over a distance of 3.5 to 4 centimeters in 40 to 60 minutes under conditions sufficiently mild so that easily inactivated substances such as mouse plasma esterases and tissue extract isoenzymes suitable for quantitative studies can be separated simultaneously on the same gel.
In comparing the electrochemistry of this disclosure with the method described by Ornstein and Davis in US. Pat. No. 3,384,564, particular attention must be paid to their FIGS. 1, 2, and 3 and our FIGS. 2-5. It is evident that, at all times, as shown in their FIGS. 1 and 2 that the totality of the protein sample or particles to be separated, is located or sandwiched between the trailing glycine ion and the leading chloride ion, in a zone relatively depleted of leading and trailing ions; thus all particles or proteins are in a region of high-voltage gradient. However, this is in a supporting medium with a pore size that is large in relation to the diameters of the various proteins so the proteins will separate in this zone on the basis of their charge density alone with no separation based on size. Once this whole region, i.e., the sandwich of glycine, protein and chloride, reaches the separating gel region of pH 8.9 the proteins are slowed down by the sieving action of the small pore size gel and the glycine mobility increases due to the increase in pH. The glycine then passes through the entire stack of proteins to migrate directly behind the chloride ion. From this point on, separation is carried out by conventional electrophoresis. However,'an ultrathin starting zone consisting of all the proteins or particles was produced at that point in time when the gylcine started to pass through the proteins.
Also it should be noted in their procedure (FIG 1) that prior to the application of electrical energy to the system the trailing glycine ion (located in the upper buffer reservoir) is in direct physical contact with a part of the protein or particles to be separated. Thus the steady state stacking," the basis of the thin starting zones and resolving power of their technique, takes place in a sandwich bounded by the leading and trailing ions between the two ion boundaries.
BUFFER SELECTION It has been determined that the resolution of these techniques depends on the selection of the discontinuous buffer ions. As indicated in table I, the mobility of the leading and trailing ion boundaries at a given power level is dependent on the combined transport numbers of the ions involved, rather than on the free mobility of the leading ion alone. Thus, under identical power conditions the chloride-glycine front mobility is greater than sulfate-glycine, which in turn, is greater than citrate-glycine, while chloride-borate is greater than sulfate-borate which is greater than citrate-borate, even through the mobilities of the leading ions alone are in the reverse order of mobility. As indicated in table 1, the greater the mobility of the ion fronts, the greater is the ratio of front mobility to the mobility of the particles to be separated. From the two extreme cases stated, i.e., chloride-glycine where the fronts are farthest separated and citrate-borate where the fastest particle (a prealbumin) travels directly on the trailing ion front, overall resolution was found to be best when the ratio of the ion fronts mobility to the fastest particle's mobility was closest to one. The most striking example appears in some esterase isoenzyme separations of tissue extracts. The choice of the best leading and trailing ions for maximal resolution in our system can be determined to be related to the ratio of the mobility of the ion boundary to that of the fastest particle to be separated after such particle has migrated a unit distance. Thus the lowest ratio tends to produce the best resolution.
TABLE 1 a pH dependency on temperature which makes sulfate a somewhat better choice for some applications.
SLAB PREPARATION The polyacrylamide slab (FIGS: 2-5) in cell 14.51 (FIG. 1a) is prepared in two or more layers of recrystallized acrylamide at the desired gel concentration and at the same pH, with five layers typically being used in plasma protein and isoenzyme separations. As shown in FIGS. 2-5, for plasma separations a lower separating layer 36 of between 8 8 Sipercent gel is followed by a layer 34 of between 6 6 1% percent gel which is overlayered directly on layer 36. Layer 34 is then waterlayered to produce an optically flat surface and a 4 A percent gel layer 32 is cast on top, waterlayered and allowed to polymerize. Wells 22 are then cast on top of this layer, with the aid ofa well former (not shown), of between 8 8 1% percent gel, at an ionic strength 1/5 to l/lO of the previously casts gels. Samples 20 in 50 percent sucrose buffered to the same pH and ionic strength as the gel columns separating each well are then placed in the wells. Following application of the sample, each well is then filled to the top level of the cell with between 8 8 as percent acrylamide gel, at the lower ionic strength and consists of the gel cap 30. The interface between the 4 '25 percent gel and the 6 6 A percent gel should be an Boundary and plasma albumin from mobility at 75 me. constant current, pH 9.35, and
1 to 6 conductivity shift for various leading-trailing ion combinations A study of the conductance of these various systems sug gests only slight differences, if any, in electrochemical behavior between systems utilizing a conductivity shift and discontinuous buffer ions at a continuous pH for at least 20-30 minutes. However, in the case of chloride-glycine, sulfate-glycine and sulfate-borate, the distance between the ion fronts increases with time. There is then a decrease in conductance, i.e., an increase in cell impedance. This is most marked in the chloride-glycine system where the ion fronts are separated by about 3 millimeters by the time the albumin front has migrated about 3.5 millimeters with a resultant drop in conductance of approximately 33 percent. On the other hand, the sulfate-borate fronts separated by only 0.25 to 0.35 millimeters during the same time the albumin migrates a similar distance, with a drop in conductance of less than 5 percent. Thus, the sulfate-borate system appears to be more desirable as it produces a higher field strength across the boundary,
throughout the separation process. There is, however, a
marked difference between those systems utilizing discontinuities in both the buffer ions and pH and in those not utilizing a conductivity shift.
The effect of the conductivity shift in the initial phase of separation indicates that this is a necessary part of the total electrochemistry of the system for optimal resolution of various particle laminae, particularly in the high molecular weight macroglobulin and haptoglobin regions and in the lower molecular weight alphai -globulin region.
Thus, for optimal resolution in a minimal running time, either the sulfate-borate or citrate-borate leading-trailing ion combination is preferred, with the sulfate-borate system being somewhat faster. Furthermore, borate, sulfate and citrate ions do not produce an initial pink background in the gel following reactions for esterase isoenzymes as does glycine. Thus, borate-sulfate or borate-citrate are also preferable not only in 551E666 bu t beea use they produce less background for subsequent densitometric studies. However, citrate, like Tris, has
optically flat surface for optimal resolution.
Since acrylamide monomer in the standard commercially available form contains numerous impurities injurious to several enzyme systems, optimal separations and reproducibility require the use of recrystallized monomer.
RECRYSTALLlZATlON PROCEDURE Dissolve grams of acrylamide monomer in a mixture of 300 ml. ethyl acetate and 300 ml. of benzene and bring to 70 C. in a water bath.
Filter hot into a heated l,000 ml. florence flask through Whatman No. 1 paper in a jacket heated funnel to prevent crystallization.
Following filtration, the monomer should be recrystallized in an ice water bath. The temperature of solution in the flask should not be allowed to drop below 20 C. The crystals are then removed by vacuum filtration in a Buchner funnel with No. l Whatman paper. The crystals are dried until there is no further odor of benzene. They are then redissolved in 540 ml. of chloroform and heated to 60 C. in a water bath. The solution is again filtered hot and then cooled to no lower than 22 C. and the crystals removed again by vacuum filtration.
Dropping the temperature in the second (chloroform) step below 22 C. has proven to produce an unsuitable monomer for use in esterase isoenzyme studies.
Crystals may be stored in the cold by placing them in a dark bottle and adding just enough chloroform to cover the crystals. Monomer stored using this procedure has been found to produce suitable isoenzyme separations after 5 months storage at 8 C. Since acrylamide is very reactive monomer, several useful hints and observations may be used to indicate the shelf life of each recrystallized batch.
A pH change of0.4 units from the 4.9-5.2 pH of the freshly recrystallized monomer and problems of removal of gel from the cells are both early signs which indicate that the monomer is deteriorating and which can be determined before changes in isoenzyme resolution become apparent.
To cast gels utilizing any of the systems of TABLE 1, the following gel buffer stock solutions are prepared:
1a. Tris citrate pH 9.0 1.5M:
36.3 gm. tris (hydroxy methyl amino methane) 28,0 ml. 1 M citric acid 0.? gldmb l,N,N',N'-tetramethylethylenediamine (TEMED) H Resulting pH of 9.0 at room temperature Tris citrate pH 9.0 0.30M:
20.0 ml. trls citrate 1.5M pH 9.0 from above 0.19 ml. TEMED H 0 to 100 ml.
50% sucrose trls citrate pH 9 0.075M bufiered:
6.25 ml. tris citrate pH 9.0 0.30M from above 12.5 grn. sucrose 0.1 n11. 0.1% aqueous bromphenol blue Final volume 25 ml. Tris sulfate pH 9.0 1.5M:
36.3 gm. tris (hydroxy methyl amino methane) 62.0 ml. N/1 H1504 0.48 ml. TEMED (N,N,N,N-tetremethylethylenediamine) H1O to 200 ml.
Tris sulfate pH 9.0 0.30M:
20.0 ml. trls sulfate pH 9.0 1.5M from above 0.19 ml. TEMED (tetramethylethyienediamine) H1O to 100 ml.
. 50% sucrose trls sulfate pH 9.0 0.075M buffered: 6.25 ml. trls sulfate pH 9,0 0.30M from above 12.5 gm. sucrose 0.1 ml. 0.1% aqueous bromphenol blue 11.0 ml. H2O
Final volume 25 ml.
. Tris chloride pH 9.0 1.5M:
36.3 gm. tris (hydroxy methyl emino methane) 40.0 ml. N/l HC TEMED (N,N,N,N'-tetramethylethylenediamine) Hi0 to 200 ml. Tris chloride pH 9.0 0.30M: 20.0 ml. tris chloride pH 9.0 1.5M from above 0.19 ml. TEMED (tetramethylethylenediamine) H1O to 100 ml.
. 50% sucrose trls chloride pH 9.0 0.75M buttered 6.25 ml. trls chloride pH 9.0 0.30M from above 12.5 gm. sucrose 0.1 ml. 0.1% aqueous bromphenol blue 11.0 ml. H1O
Final volume 25 ml.
The following buffers are applicable:
All molarities refer to molarity of tris. All pH refer to pH at 25C.
Stock solution 60 is a stock persulfate catalyst solution prepared fresh daily and consists of 0.105 g. ammonium persulfate diluted to 100 m1. Stock 6b is a similar stock persulfate catalyst at double the concentration of 6a, i.e., 0.21 g./ 100 ml.
Stock solution 7 32 percent acrylamide (if final lower separating layer of 8 percent gel is desired) Icg?somereer samzea mamnar'- 0.12 g. methylene bis acrylamide H O to a final volume of 15 ml.
This stock solution is prepared fresh daily.
The cell is clamped in an appropriate gelling stand and the stand leveled. A gasket is usually provided at the base of the cell to prevent leakage during additionof reagents.
In the upright position approximately 20 ml. of 8 percent gel consisting of ml. of stock gel buffers 10, 2a or 3a, plus 5.0 ml. of stock solution 7, plus 10 ml. of stock solution 60 is mixed in a beaker at room temperature and poured into the gel. Immediately 3.4 ml. of 6 percent monomer concentration consisting of 1.2 ml. stock solution la, 20 or 3a, 0.90 ml. of stock solution 7, 0.30 ml. H 0 and 2.4 ml. of stock solution 6a is carefully overlayered on top of the first layer. This layer is then carefully waterlayered from one or both edges of the cell and the two layers of monomer allowed to polymerize. Two
milliliters of a 4 A percent gel consisting of 0.80 ml. of stock solution la, 2a or 3a, 0.45 ml. of stock solution 7, 0.35 ml. of H 0 and 1.6 ml. of stock solution 6b is added and waterlayered. Following polymerization, 3.6 ml. of 0.075 molar 8 percent gel consisting of 0.90 ml. of stock solution 7, 0.90 ml. of stock solution lb, 2b or 3b and 1.8 ml. of stock solution 6b, is added, a well former inserted with the bottom edges of the well former resting on top of the 4 1% percent layer, and the gel allowed to polymerize for at least 20 minutes. The well former is then removed and the wells rinsed with distilled H 0 and then drained carefully by inverting the cell. The cell is then placed in the upright position and the sample (200 to 1,000 ug. of protein per wall depending on the test) in 20 pl. of 0.075 molar 50 percent sucrose from stock solution it", 2c or 30 is placed in the well.
Next, 0.075 molar 8 percent sealing gel is added carefully on top of each sample layer. This sealing gel consists of 1.0 ml. of stock solution 7, 1.0 ml. of stock solution lb, 2b or 3b, and 2.0 ml. of stock solution 6a. This is allowed to gel and the cell is then ready for electrophoretic separation.
Solutions 1, 2 or 3 must not be intermixed in the same gel, as each gel slab contains either all Tris citrate (solutions la, lb and 1c) or all Tris sulfate (solutions 2a, 2b and 2c) or all Tris chloride (solutions 3a, 3b and 3c).
Should one wish to perform ascending electrophoresis, the cell is cast in the inverted position and the polarities at jacks 12.1, 14.1 (FIG. la) reversed.
Electrophoresis is usually performed in the vertical position, preferably with the negatively charged electrode 16.2 (FIG. 1) in the upper tank 14 and the positively charged electrode 12.2 the the lower tank 12. The lower tank is filled with Tris-borate buffer at 40 C., giving a pH of 9.35 to 9.40, to a level even with the bottom of the upper buffer tank 14. The cell or cells 14.51 containing the gel slab l8 and sample 20 are inserted through slots 14.5 in the upper tank 14. To prevent leakage between the upper and lower tank, the cell end plates are sealed to the floor of the upper tank by pressing the cell and plate into a head of silicone grease or a special sealing gasket (not shown). Then sufficient Tris-borate is poured into the upper tank to cover the platinum electrode wire 16.2. Thus, the gel serves as a bridge between the two electrodes and the cell is completely immersed in a large volume of cold buffer for additional cooling during electrophoresis.
LII
An electromotive force is then applied across the cell, preferably in the form of constant power pulses, such as described in the aforementioned copending patent application of Robert Dillwoth, 111.
The pulse rate is initially set at a level so that a power level at about 45 milliwatts per mm. gel surface is achieved, c.g., for a standard cell, 3.5 mm. width, 100 mm. length and 90 mm. depth, a peak voltage of about 700 v. is discharged through a 1.0 microfarad capacitor at a rate of about 45pulses per second. The power level is then raised to milliwatts/mm. (125 p.p.s.) after 5 minutes. Following completion of the initial conductivity shift step in the separation, 12-15 minutes, the power is raised in two steps to and .milliwatts/mm. at 15 and 20 minutes, respectively (200 and carried out for both protein and isoenzyme separations typically at power levels of 100 milliwatts/mm. gel surface, although higher power levels with shorter run times may be used. Voltage level is kept constant throughout a given run.
For two-cell operation, power setting of about 400 volts and similar pulse rates are used during the first stage conductivity shift, then the power level is raised by bringing the pulse rate to about 225 p.p.s. and 350 p.p.s. at 15 and 20 minutes, respectively.
Pulsed power electrophoresis is carried on until the albumin front migrates a distance of 3.5 to 4.0 cm.,'a matter of 40 to 60 minutes depending on whether the divalent sulfate or trivalent citrate ions are used as the leading ion.
Following electrophoresis the upper buffer tank is removed, the buffer discarded and the cell removed. Excess sealing grease is removed from the end plate and the gel is ready for provides the best results. Thus a gel may be readily removed from a cell in one to two minutes.
Following removal, the gel may be stained in a common protein dye (such as Amido Black) in 10 percent acetic acid overnight or for 2 hours at 65 C. and then destained by electrophoresis or repeated washing in 10 percent acetic acid with about five acid changes in two days.
Alternatively, the gels may be placed in a pH 6.6, 0.04 M Tris-chloride buffer at 37 C. for 5 minutes and then into a dye substrate system of fast blue RRa-napthyl butyrate at pH 6.6 for minutes for the quantitative development of nonspecific esterase isoenzymes. Some fifty other isoenzyme staining procedures previously described are amenable to these techniques of separation.
While the conditions described in detail here are applicable to plasma and tissue extract proteins and isoenzymes, it will be obvious to those skilled in the art of electrophoresis that with the system described herein, ion selection and pH conditions and gel pore sizes can be varied widely, making the system suitable for separations of a wide variety of charged particles. Thus, for example, positive charged particles will behave in a Til (e manner if appropriate changes are madeinbuf fer and pH, or separations may be carried out with negative ions at low or lower pH levels than those specifically described for plasma and certain tissue extracts above.
While there has been described what is presently considered the preferred embodiments of the invention, it should now be obvious to those skilled in the art that various other changes and modifications may be made therein without departing from the inventive concept contained herein, and it is, therefore, aimed to cover all such other changes and modifications that may fall within the true spirit and scope of the invention.
What is claimed is:
1. In an electrophoretic process for concentrating and then separating certain components of a mixture of like signcharged particles through a sieving gel medium, the gel medium having a plurality of contiguous zones; the particles suspended in solution adjacent the gel medium; having a pair of electrodes of opposite polarity, each electrode positioned at opposite end of the gel medium; a source of power for connection to the electrodes; and a buffer solution surrounding the gel medium and the electrodes, the improvement comprising:
initially positioning the particle solution between two gel zones;
providing a source of ions of like sign nd of different mobilities in both the buffer solution and the gel medium; providing the faster ion in the gel medium and the slower ion in the buffer solution; and applying a source of constant, pulsed DC field across the gel medium during the concentrating and separating process.
2. The process of claim 1 further comprising:
providing a single gel zone between the particle solution and the buffer solution;
lowering the conductance of both the single gcl zone and particle solution to raise the voltage gradient appearing thereacross; and
maintaining all gel zones, the particle solution and buffer solution at the same pH.
3. The process of claim 2 wherein the buffer solution is a member of the group consisting of citrate-borate, sulfateborate and chloride-borate.
4. The process of claim 3 wherein the buffer solution is citrate-borate.
5. The process of claim 3 wherein the buffer solution is sulfate-borate.
6. The process of claim 3 wherein the buffer solution is chloride-borate.
22 3 UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3 ,9 +7 Dated November 1 6, 197] Inventor(s) Robert Carter AI Ien and Dorothy J. Moore It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Co1umn 3, I ine 33, before "on" insert -Fi led".
0 Column 8, line 33, delete IO and insert Column 8, I ine 53, deIete "'45" and insert --75- Column 10, 1 Ine I5, delete "nd" and insert --and--.
Siqned and sealed this 8th day of May 1973.
(SEAL) Attest:
EDWARD M.FLETCHER,JR. ROBERT GOTTSCHALK Attesting Officer Commissioner of Patents

Claims (5)

  1. 2. The process of claim 1 further comprising: providing a single gel zone between the particle solution and the buffer solution; lowering the conductance of both the single gel zone and particle solution to raise the voltage gradient appearing thereacross; and maintaining all gel zones, the particle solution and buffer solution at the same pH.
  2. 3. The process of claim 2 wherein the buffer solution is a member of the group consisting of citrate-borate, sulfate-borate and chloride-borate.
  3. 4. The process of claim 3 wherein the buffer solution is citratE-borate.
  4. 5. The process of claim 3 wherein the buffer solution is sulfate-borate.
  5. 6. The process of claim 3 wherein the buffer solution is chloride-borate.
US815145A 1969-04-10 1969-04-10 Electrophoretic system Expired - Lifetime US3620947A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81514569A 1969-04-10 1969-04-10

Publications (1)

Publication Number Publication Date
US3620947A true US3620947A (en) 1971-11-16

Family

ID=25216995

Family Applications (1)

Application Number Title Priority Date Filing Date
US815145A Expired - Lifetime US3620947A (en) 1969-04-10 1969-04-10 Electrophoretic system

Country Status (1)

Country Link
US (1) US3620947A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856655A (en) * 1973-01-15 1974-12-24 Bovril Ltd Vertical gel electrophoresis apparatus
US4306956A (en) * 1980-11-10 1981-12-22 Miles Laboratories, Inc. Discontinuous gel electrophoresis process
US4415418A (en) * 1980-12-22 1983-11-15 Turre Gilles H J Gel electrophoresis device and method
US5078853A (en) * 1991-03-22 1992-01-07 Assay Technology, Inc. Segmented electrophoretic separation system useful for lipid profiling
US6602661B1 (en) 1999-07-26 2003-08-05 20/20 Genesystems, Inc. Methods and arrays for detecting biomolecules
US20040081979A1 (en) * 1999-07-26 2004-04-29 Vladimir Knezevic Methods, devices, arrays and kits for detecting and analyzing biomolecules
US20060147926A1 (en) * 2002-11-25 2006-07-06 Emmert-Buck Michael R Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array
US20060211011A1 (en) * 1999-07-26 2006-09-21 Vladimir Knezevic Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
US7214477B1 (en) 1999-07-26 2007-05-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Layered device with capture regions for cellular analysis
US20110042217A1 (en) * 2009-08-24 2011-02-24 Life Technologies Corporation Electrophoresis gel cassette and comb
USD794823S1 (en) 2010-08-24 2017-08-15 Life Technologies Corporation Electrophoresis tank with a base and cassette inserted in
USD795449S1 (en) 2012-06-01 2017-08-22 Life Technologies Corporation Electrophoresis wedge-well retainer cassette
USD806894S1 (en) 2015-03-19 2018-01-02 Life Technologies Corporation Electrophoresis comb with wedge-shaped teeth

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384564A (en) * 1962-11-21 1968-05-21 Mount Sinai Hospital Res Found Electrophoretic process for simultaneously spearating and concentrating particles
US3470080A (en) * 1966-06-27 1969-09-30 Samuel Raymond Multi-phase electrophoretic distribution
US3506554A (en) * 1968-03-15 1970-04-14 Samuel Raymond Apparatus for separating electrophoretically active substances
US3539494A (en) * 1965-10-06 1970-11-10 Victor Pretorius Chromatographic separation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384564A (en) * 1962-11-21 1968-05-21 Mount Sinai Hospital Res Found Electrophoretic process for simultaneously spearating and concentrating particles
US3539494A (en) * 1965-10-06 1970-11-10 Victor Pretorius Chromatographic separation
US3470080A (en) * 1966-06-27 1969-09-30 Samuel Raymond Multi-phase electrophoretic distribution
US3506554A (en) * 1968-03-15 1970-04-14 Samuel Raymond Apparatus for separating electrophoretically active substances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Davis, Method and Appt. to Human Serum Proteins, Annals of the N.Y. Academy of Sciences, Vol. 121, Article 2, Page 424 Dec. 28, 1964. *
Schwalbe, Pulsed Field Electrophoresis, Medical Electronics, Internat. Conf. on Med. Electronics, Paris, 1959, QT34 I64m (1959) *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856655A (en) * 1973-01-15 1974-12-24 Bovril Ltd Vertical gel electrophoresis apparatus
US4306956A (en) * 1980-11-10 1981-12-22 Miles Laboratories, Inc. Discontinuous gel electrophoresis process
US4415418A (en) * 1980-12-22 1983-11-15 Turre Gilles H J Gel electrophoresis device and method
US5078853A (en) * 1991-03-22 1992-01-07 Assay Technology, Inc. Segmented electrophoretic separation system useful for lipid profiling
WO1992016830A1 (en) * 1991-03-22 1992-10-01 Assay Tech Inc Segmented electrophoretic separation system useful for lipid profiling
US7838222B2 (en) 1999-07-26 2010-11-23 United States of America/ NIH Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
US6602661B1 (en) 1999-07-26 2003-08-05 20/20 Genesystems, Inc. Methods and arrays for detecting biomolecules
US20040081987A1 (en) * 1999-07-26 2004-04-29 20/20 Genesystems, Inc. Methods and arrays for detecting biomolecules
US6969615B2 (en) 1999-07-26 2005-11-29 20/20 Genesystems, Inc. Methods, devices, arrays and kits for detecting and analyzing biomolecules
US8779312B2 (en) 1999-07-26 2014-07-15 United States of America/NIH Method and device for analyzing biomolecules with track-etched polymeric layers
US20060211011A1 (en) * 1999-07-26 2006-09-21 Vladimir Knezevic Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
US7214477B1 (en) 1999-07-26 2007-05-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Layered device with capture regions for cellular analysis
US20040081979A1 (en) * 1999-07-26 2004-04-29 Vladimir Knezevic Methods, devices, arrays and kits for detecting and analyzing biomolecules
US20100137160A1 (en) * 1999-07-26 2010-06-03 Vladimir Knezevic Method and Device for Analyzing Biomolecules With Track - Etched Polymeric Layers
US8283158B2 (en) 2002-11-25 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two dimensional array
US20100105056A1 (en) * 2002-11-25 2010-04-29 The United States of America as representd by the Secretary, Department of Health and Human Services Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two dimentional array
US20060147926A1 (en) * 2002-11-25 2006-07-06 Emmert-Buck Michael R Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array
US20110042217A1 (en) * 2009-08-24 2011-02-24 Life Technologies Corporation Electrophoresis gel cassette and comb
US9097663B2 (en) 2009-08-24 2015-08-04 Life Technologies Corporation Gel electrophoresis, imaging, and analysis methods, devices, systems, and materials
US9714918B2 (en) 2009-08-24 2017-07-25 Life Technologies Corporation Electrophoresis gel cassette and comb
US10613052B2 (en) 2009-08-24 2020-04-07 Life Technologies Corporation Electrophoresis gel cassette and comb
USD832458S1 (en) 2010-08-24 2018-10-30 Life Technologies Corporation Electrophoresis cassette base
USD831847S1 (en) 2010-08-24 2018-10-23 Life Technologies Corporation Electrophoresis wedge-well divider cassette
USD794823S1 (en) 2010-08-24 2017-08-15 Life Technologies Corporation Electrophoresis tank with a base and cassette inserted in
USD890363S1 (en) 2010-08-24 2020-07-14 Life Technologies Corporation Lid of an electrophoresis tank
USD795449S1 (en) 2012-06-01 2017-08-22 Life Technologies Corporation Electrophoresis wedge-well retainer cassette
USD806894S1 (en) 2015-03-19 2018-01-02 Life Technologies Corporation Electrophoresis comb with wedge-shaped teeth
USD858793S1 (en) 2015-03-19 2019-09-03 Life Technologies Corporation Electrophoresis comb with wedge-shaped teeth

Similar Documents

Publication Publication Date Title
US3620947A (en) Electrophoretic system
US3674678A (en) Electrophoretic apparatus
Davis Disc electrophoresis. II. Method and application to human serum proteins
US4416761A (en) Multi slab gel casting electrophoresis apparatus
Brewer et al. Disc electrophoresis
US3384564A (en) Electrophoretic process for simultaneously spearating and concentrating particles
US4142960A (en) Slab gel mold and electrophoresis apparatus
USRE24752E (en) Method of electrophoresis of serum proteins
US4234400A (en) Horizontal slab gel electrophoresis
JPH021544A (en) Method and apparatus used for biological test
US6361665B1 (en) Device for electroactivating fluids and preparations consisting of electroactivated fluids
US4495279A (en) Isoelectric focussing-polynucleotide/polyacrylamide gel electrophoresis
US5228971A (en) Horizontal gel electrophoresis apparatus
US5989403A (en) Electrophoresis assembly with filling means
JPS5910492B2 (en) Method of generating pH function for electrophoresis
EP0231239B1 (en) Method for electrophoretic separation
US5137613A (en) Horizontal gel electrophoresis apparatus
Kitchin Demonstration of the inherited serum group specific protein by acrylamide electrophoresis.
US6558522B1 (en) Apparatus for electrophoresis
Allen et al. A vertical flat-bed discontinuous electrophoresis system in polyacrylamide gel
WO1989000689A1 (en) High resolution electrophoretic gel and method for separating serum proteins
Neuhoff et al. Micro-electrophoresis on polyacrylamide gels
Melachouris Discontinuous gel electrophoresis of whey proteins, casein, and clotting enzymes
RILBE Trends in Instrumental and Methodical Development of Isoelectric Focusing
US3826734A (en) Apparatus for use in liquid sample analysis

Legal Events

Date Code Title Description
AS Assignment

Owner name: EG&G INSTRUMENTS, INC.

Free format text: CHANGE OF NAME;ASSIGNORS:PRINCETON APPLIED RESEARCH CORPORATION;ORTEC INCORPORATED INTO;REEL/FRAME:005521/0532;SIGNING DATES FROM